ArticleBritish journal of haematology2023

Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.

Xin Shelley Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.